Correlation Between Evoke Pharma and Allogene Therapeutics
Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evoke Pharma and Allogene Therapeutics, you can compare the effects of market volatilities on Evoke Pharma and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Allogene Therapeutics.
Diversification Opportunities for Evoke Pharma and Allogene Therapeutics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Evoke and Allogene is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Allogene Therapeutics go up and down completely randomly.
Pair Corralation between Evoke Pharma and Allogene Therapeutics
Given the investment horizon of 90 days Evoke Pharma is expected to under-perform the Allogene Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Evoke Pharma is 1.51 times less risky than Allogene Therapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The Allogene Therapeutics is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 209.00 in Allogene Therapeutics on October 25, 2024 and sell it today you would lose (17.00) from holding Allogene Therapeutics or give up 8.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Evoke Pharma vs. Allogene Therapeutics
Performance |
| Timeline |
| Evoke Pharma |
| Allogene Therapeutics |
Evoke Pharma and Allogene Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evoke Pharma and Allogene Therapeutics
The main advantage of trading using opposite Evoke Pharma and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.| Evoke Pharma vs. Petros Pharmaceuticals | Evoke Pharma vs. Cumberland Pharmaceuticals | Evoke Pharma vs. Painreform | Evoke Pharma vs. Aquestive Therapeutics |
| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |